General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ferrari D et al. – The results of that trial seem to indicate a third agent added to CDDP and 5–FU improved both PFS and OS in the recurrent or metastatic setting. Unfortunately, the results obtained with the tyrosine kinase inhibitors are less impressive, and additional studies are needed to explore the potentiality of this class of drug.

Today in Head and Neck...keeping you current

Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosis
The Laryngoscope, 12/10/09

Head and neck sequelae of torture
The Laryngoscope, 12/10/09

Role of surgical management in temporal bone fibrous dysplasia
Acta Oto-Laryngologica , 12/10/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address